140
Participants
Start Date
August 18, 2017
Primary Completion Date
July 19, 2018
Study Completion Date
March 31, 2026
E7389-LF
intravenous infusion
Eisai Trial Site 3, Kashiwa
Eisai Trial Site 5, Sapporo
Eisai Trial Site 8, Nishinomiya
Eisai Trial Site 6, Yokohama
Eisai Trial Site 10, Hidaka
Eisai Trial Site 9, Bunkyo-ku
Eisai Trial Site 1, Chuo-ku
Eisai Trial Site 4, Koto-ku
Eisai Trial Site 7, Shinjuku-ku
Eisai Trial Site 12, Fukuoka
Eisai Trial Site 11, Kyoto
Eisai Trial Site 2, Osaka
Eisai Co., Ltd.
INDUSTRY